Clinical study to prove the efficacy and safety of topical timolol for infantile hemangiomas

Clinical study to prove the efficacy and safety of topical timolol for infantile hemangiomas - Topical timolol for infantile hemangiomas

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005387

Enrollment

Registered

2011-05-09

Start date

2011-05-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infantile hemangiomas

Interventions

Group A: dye laser Group B: dye laser + topical timolol ophtalmic solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: infantile hemangiomas

Exclusion criteria

Exclusion criteria: heart disease, asthma, severe complication, allergy for timolol ophtalmic solution

Design outcomes

Primary

Measure	Time frame
change in size of infantile hemangiomas	—

Secondary

Measure	Time frame
photographic evaluation evaluation of efficacy by doctor evaluation of efficacy by family presence or absence of complications	—

Countries

Japan

Contacts

Public ContactAkiko Kishi

Toranomon Hospital Dermatology

03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026